<DOC>
	<DOCNO>NCT00939497</DOCNO>
	<brief_summary>Objective : - To assess bioequivalence Risperidone 1.0 mg tablet Torrent Pharmaceuticals Limited. , India Risperdal® ( Risperidone ) 1.0 mg tablet Janssen Pharmaceutical Products , LP , USA , healthy human adult subject , fast condition . Study Design : - A randomized , open label , two treatment , two period , two sequence , single dose , crossover study , fast condition .</brief_summary>
	<brief_title>Bioequivalence Study Risperidone 1.0 mg Tablets Torrent Pharmaceuticals Limited. , India Risperdal® ( Risperidone ) 1.0 mg Tablets Janssen Pharmaceutical Products , LP , USA , Healthy Human Adult Subjects , Under Fasting Conditions</brief_title>
	<detailed_description />
	<mesh_term>Risperidone</mesh_term>
	<criteria>1 . Healthy human adult subject 1855 year age ( inclusive ) , body mass index ( BMI ) 18 27 kg/m2 . 2 . Subjects evidence underlie disease screen history whose physical examination perform within 21 day prior commencement study . 3 . Subjects whose screen laboratory value within normal limit consider physician/Principal Investigator clinical significance . 4 . Informed consent give write form accord section 11.3 protocol . 5 . Female Subjects : Of child bear potential practicing acceptable method birth control duration study judge investigator ( ) , condom , foam , jelly , diaphragm , intrauterine device ( IUD ) , abstinence . Postmenopausal least 1 year . Surgically sterile ( bilateral tubal ligation , bilateral oophorectomy , hysterectomy perform subject ) . 1 . History presence significant : Cardiovascular , pulmonary , hepatic , renal , hematological , gastrointestinal , endocrine , immunologic , dermatologic , musculoskeletal , neurological psychiatric disease . Alcohol dependence , alcohol abuse drug abuse within past one year . Moderate heavy smoking ( &gt; 10 cigarettes/day ) consumption tobacco product . History difficulty swallow tablet / capsule . Clinically significant illness within 4 week start study Asthma , urticaria allergic type reaction take medication . Positive urine drug screening , HIV , Hepatitis B &amp; C test . Any history hypersensitivity Risperidone . Existence surgical medical condition , , judgment clinical investigator might interfere pharmacokinetics drug likely compromise safety subject . Inability communicate cooperate investigator due language problem , attitude , poor mental development / impair cerebral function . 2 . Subject participate clinical trial involve drug administration collection blood sample donate blood precede 12 week prior start study . 3 . Subjects : Systolic blood pressure le 90 mm Hg 150 mm Hg . Diastolic blood pressure le 60 mm Hg 94 mm Hg . Minor deviation ( 24 mm Hg ) checkin may acceptable discretion physician /investigator . Pulse rate 50/minute 105/minute .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2009</verification_date>
</DOC>